ICER’s Dr. Steve Pearson and the COVID drug pricing model
Nov 12, 2020•33 min•Season 1Ep. 8
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
Drug pricing is the hottest topic in healthcare, and ICER founder Dr. Steve Pearson is the coolest person to discuss it with. In this episode of the HealthBiz podcast, Steve describes how ICER compiles and analyzes clinical evidence to estimate the fair value of treatments for COVID-19 and other serious illnesses.
As of March 2025 HealthBiz is part of CareTalk. Healthcare. Unfiltered and can be found at the following links:
- Spotify https://open.spotify.com/show/2GTYhbNnvDHriDp7Xo9s6Z
- Apple https://podcasts.apple.com/us/podcast/caretalk-healthcare-unfiltered/id1532402352
- YouTube https://www.youtube.com/@CareTalkPodcast
- CareTalk website https://www.caretalkpodcast.com/
Host David E. Williams is president of healthcare strategy consulting firm Health Business Group.
Episodes through March 2025 were produced by Dafna Williams.
For the best experience, listen in Metacast app for iOS or Android